NCT00354172 · OUTCOME

Chimerism After Double Umbilical Cord Blood Transplant (UCBT)

Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers. · Source last updated 2017-12-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: MEDIAN
Unit: Percentage of Engrafted Cells
Interval / dispersion: Full Range
Time frame: Day 21, Day 100, 6 Months

What was measured

Calculation of Median (range) of percentage of donor cells engrafted (present) in the recipient (patient).

Analysis population: 1 Year and 2 Year Post Transplant data was not applicable; no patients reached this timeframe to evaluate.

Groups in this outcome

Evaluable Patients

All patients receiving full study treatment with chemotherapy and radiation, along with natural killer cells, aldesleukin and umbilical cord blood transplant.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Evaluable Patients	15

Reported measurements

Day 21

Values in Percentage of Engrafted Cells · Interval/dispersion: Full Range
Group	Value	Spread	Lower	Upper	Comment
Evaluable Patients	92	Not reported	14	100	Not reported

Day 100

Values in Percentage of Engrafted Cells · Interval/dispersion: Full Range
Group	Value	Spread	Lower	Upper	Comment
Evaluable Patients	100	Not reported	47	100	Not reported

6 Months

Values in Percentage of Engrafted Cells · Interval/dispersion: Full Range
Group	Value	Spread	Lower	Upper	Comment
Evaluable Patients	96.5	Not reported	93	100	Not reported

Complete source fields

anticipated Posting Date

2009-11

classes

categories
measurements
group Id
OG000
lower Limit
14
upper Limit
100
value
92
title
Day 21
categories
measurements
group Id
OG000
lower Limit
47
upper Limit
100
value
100
title
Day 100
categories
measurements
group Id
OG000
lower Limit
93
upper Limit
100
value
96.5
title
6 Months

denoms

counts
group Id
OG000
value
15
units
Participants

description

Calculation of Median (range) of percentage of donor cells engrafted (present) in the recipient (patient).

dispersion Type

Full Range

groups

description
All patients receiving full study treatment with chemotherapy and radiation, along with natural killer cells, aldesleukin and umbilical cord blood transplant.
id
OG000
title
Evaluable Patients

param Type

MEDIAN

population Description

1 Year and 2 Year Post Transplant data was not applicable; no patients reached this timeframe to evaluate.

reporting Status

POSTED

time Frame

Day 21, Day 100, 6 Months

title

Chimerism After Double Umbilical Cord Blood Transplant (UCBT)

type

SECONDARY

unit Of Measure

Percentage of Engrafted Cells

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice